Suicide Eventually Touches Everyone
Henderson, NV, October 12, 2018 — Each suicide touches at least seven people, impacting them deeply for the rest of their lives.
Consider the following:
• There are an estimated 380 attempted suicides among teenagers daily.
• Each day, 22 veterans of armed services commit suicide.
• Every other day, one law enforcement officer commits suicide.
• Close to 400 doctors commit suicide each year.
In 1986, Matthew D. Dovel, scientist in human behavioral modification, killed himself. He didn't stay dead. But he had a near-death experience. A book was written about his ordeal, and he was interviewed on numerous TV, and radio shows, such as Good Morning America, 20/20, I survived … beyond and back, and many more.
Upon his return, he claims that God gave him new insights into how the mind works: IT IS MECHANICAL!
Mr. Dovel created treatments based on the information that was given to him, copyrighted them, and trademarked the system now known as Nu-Rekall®, a noninvasive and nonmedical treatment. Nu-Rekall® treatments are a singular application, like turning off an engine, requiring only 5 to 20 minutes to complete. They can be facilitated one on one, over the phone, through self-help, and/or covertly, and can be used in the treatment of depression, bipolar disorder, PTSD, anxiety and suicidal ideation.
Mr. Dovel has developed free self-help resources and displays this information on a nonprofit he founded in 2006 called International Suicide Prevention or ISP. ISP is a 501(c)(3) public charity nonprofit: https://www.supportisp.org. Since 2006, Mr. Dovel has personally answered the phone on ISP's 24/7 suicide prevention hotline.
For more information on Matthew Dovel and Nu-Rekall®, please visit:
www.supportisp.org
www.facebook.com/matthew.dovel.3
www.linkedin.com/in/suicidepreventionexpert/
###
TIP SHEET
Sample interview questions for Matthew Dovel:
1. How do Nu-Rekall® treatments work exactly?
2. Are there any side effects?
3. Have you been able to teach others this new psychology?
4. Do the treatments last?
5. How many have been treated so far?
6. What is the next step in treating the masses?
7. Where do you eventually see Nu-Rekall® 50 years from now?
Matthew Dovel's TV news interviews on suicide prevention:
• World Suicide Prevention Day Concert 2007
• https://youtu.be/X2KaETeiFGc
• World Suicide Prevention Day: Las Vegas News 3 - 2007
• https://youtu.be/zfqJTcBIEE8
• Fairbanks, Alaska News CBS Suicide Prevention – 2008
• https://youtu.be/z3FU_dg8ulI
• NBC News 3 Las Vegas: Suicide Rates on the Rise - 2009
• https://youtu.be/QGqrMbeIYMQ
• World Suicide Prevention Day: Good News CBS Channel 8 -2014
• https://youtu.be/HGzuB1DxZrQ
• Veterans Day: Help for the Veterans Nu-Rekall® NBC News 3 -2014
• https://youtu.be/QmmVL1rCtCU
• Paula Vail interview Aired live on September 23, 2017 - WBTVN.TV 3pm (cst) Global network
• https://www.linkedin.com/feed/update/urn:li:activity:6317469380821286912
• Chuck Morse June 18, 2018
• https://youtu.be/HkfrWb_gUsg
Reference articles:
• "Advanced online course in cognitive neuropsychology cognition by Nu-Rekall® mind science technologies. A limited opportunity.”
https://www.linkedin.com/feed/update/urn:li:activity:6314961922404024320
• "Why do people commit suicide?" https://www.linkedin.com/pulse/why-do-people-commit-suicide-matthew-d-dovel
• "Breakthrough: New treatments for Mental Illnesses" https://www.linkedin.com/pulse/breakthrough-new-treatments-mental-illnesses-matthew-d-dovel
• "The 5 New Universal Laws of the Mind" https://www.linkedin.com/pulse/5-new-rules-mind-matthew-d-dovel
• "Got P.T.S.D.? We can now fix that!" https://www.linkedin.com/pulse/got-ptsd-matthew-d-dovel
• "Discovery: The Rosetta Stone for the Mind..." https://www.linkedin.com/pulse/discovery-rosetta-stone-mind-matthew-d-dovel
Loss Is A Four-Letter Word: A Bereavement Boot Camp for the Widowed
By Carole Brody Fleet
"Carole Brody Fleet is forthright in dealing with many of the difficult issues surrounding widowhood, demonstrating that you do not have to live in your past. It's not an either-or situation. She teaches the important lesson that you can incorporate your previous life into a new life.”
—Jane Brody, personal health columnist, The New York Times
Deerfield Beach, FL, October 12, 2018 — No widow or widower look exactly the same. No widowhood looks exactly the same. Therefore, no healing journey or timeline is an identical experience. The word "loss” contains only four letters, but its size belies the amount of fear it produces at even its mere mention. Even more terrifying and enormous is the reality of loss–specifically, the loss of a spouse.
Widowhood has the capacity to keep those affected from moving forward into a new and fulfilling life. The loss of a spouse is frightening. The call for relatable and actionable direction and advice remains a very real need for the widowed community, and that is just what Loss is a Four-Letter Word offers. Award-winning author Carole Brody Fleet personally experienced the pain and grief as a young widow and mother; leaving her and her 9-year-old daughter alone. Loss is a Four-Letter Word shows readers a way out, a way to move forward– not "get over”–their most profound loss in positive ways. Fleet combines no-nonsense, direct advice with specific, boot-camp style "assignments” that are framed with compassion and humor to help them through a most challenging life-journey.
A short sample of the Bereavement Boot Camp Lessons:
• Lesson One: I'm Still Here
• Lesson Two: "My Healing Journey Is Mine”
• Lesson Three: Stop Putting Off Proactivity
• Lesson Four: "I Turn to… Who?”
• Lesson Five: Put Your Tits on Your Back
• Lesson Six: Get Up, Get Moving… Get Out!
• Lesson Seven: It's Your Turn
• Lesson Eight: Past, Present, and Future: You Can Have All Three
Loss is a Four-Letter Word gives readers help without reproach, education without lecture, and support without judgment, condition, or negative opinion. All of which provides a necessary light during such devastating times. Fleet tells them, "Because while our spouses may have departed this earth, we are still here. And we matter too.”
About the Author:
Carole Brody Fleet is the award-winning author of When Bad Things Happen to Good Women, Happily EVEN After, and Widows Wear Stilettos. Widely recognized as America's go-to expert on life adversity and grief recovery, Ms. Fleet is also a three-time contributor to the iconic Chicken Soup for the Soul book series, as well as a regular contributor to The Huffington Post and to ThirdAge.com. Ms. Fleet is also a popular motivational speaker and with her inimitable message of "What Now and What Next?” Ms. Fleet offers practical, emotional, and even humorous guidance to the millions who have experienced any kind of loss or challenge in their lives.
Loss Is A Four-Letter Word: A Bereavement Boot Camp for the Widowed
By Carole Brody Fleet
ISBN: 9780757321214
September 2018
$15.95
Available wherever books are sold or to order directly from the publisher, contact:
(800) 441-5569 or www.hcibooks.com
###
Reviews:
Karen Noé, author, We Consciousness: 33 Profound Truths for Inner and Outer Peace and Your Life After Their Death: A Medium's Guide to Healing After a Loss: "Carole Brody Fleet has done it again! In Loss is a Four Letter Word, she offers practical, straightforward advice on how to move forward on a positive path after losing a loved one. I've had Carole as a guest on the "Angel Quest” radio show a number of times because of how much she has benefited my listeners with her knowledge. If it sounds like I am impressed with her, it's because I am. I love this book, and I love Carole!”
Lisa Lockwood, crime analyst, author, police and military veteran: "What I love and appreciate is Carole Brody Fleet's firsthand knowledge and approach on the most taboo topic in society. Having gone through personal loss, I always learn something about how to approach the topic with empathy and how to permit others to comfort me in the worst of times.”
Stacey Gualandi, Emmy award-winning journalist: "Carole Brody Fleet has faced painful challenges and loss with courage and resilience. Through her own personal healing, we can all learn from and be inspired by her. I have a four-letter word for Carole: HERO.”
Kristin Higson-Hughes, Senior Features Editor, Women's World Magazine: "Just as there is no timetable to grief, there certainly is no checklist on how to recover strength and joy after suffering a loss. Here you will find authentic, candid, trustworthy, and--perhaps most pertinent of all--pragmatic advice promising that although the landscape of life may forever be changed, the future can still hold purpose, beauty, and magic. With a signature style all her own, Carole Brody Fleet "trains" you to find yourself again (hint: there's no wrong path, but some are healthier for your soul!). Together, you will navigate everything from social media to financial matters to the possibility of finding love again. Sure, it can feel impossible to do, and even more so to find answers, but sign up, dear recruit, and discover this book's wit and wisdom, and its author's enormous-as-the-universe heart!"
Kim Iversen, nationally syndicated radio show host: "Carole is an angel, not just an expert. Many of us have no clue what to say to a loved one going through tremendous loss. We sit by and watch helplessly as they struggle with their 'new normal'. Carole's book is a must read; not just for widows, but for those of us who love a widow as well. As a relationship radio talk show host, I have always had words to comfort and guide someone through every type of heartache-----every heartache except the death of a spouse. This type of loss leaves many of us speechless. Finally, someone who knows what to say when the rest of us do not."
Longest-Living Lung Cancer Survivor Shares The Plan That Helped Him Beat Cancer
Hampton, VA, October 12, 2018 — No one wants to hear from their doctor that they have cancer, and only six months to live. But these are the words that Dr. Carl O. Helvie heard 44 years ago. While his doctor encouraged him to begin traditional treatment right away, Helvie knew there had to be another way to treat his cancer without the negative side effects of radiation and chemotherapy, or the invasiveness of surgery. After a lot of praying and a good amount of soul-searching, he opted to look for an alternative way to beat his cancer.
Today, Dr. Helvie is the longest-living lung cancer survivor in the world and he credits this with his decision to take a holistic approach in his treatment. His treatment proved so successful, Dr. Helvie used it to develop a simple plan that he shares in his new book, Reducing Your Cancer Risk: A Holistic Approach (Booklocker Inc.). It's not complicated—it's not rocket science—but it is based on years of proven research. The book explores the environment that brings cancer and the human body together, and offers steps to take before these three elements interact to cause the disease.
Listed in '50 Great Writers You Should Be Reading in 2014,' Helvie recommends anyone receiving a cancer diagnosis to take the time to really think about what they want to do for their treatment plan. Adding, "People shouldn't jump into chemotherapy or surgery if they don't have all of the information and have a chance to think about it."
In 2014, Dr. Helvie founded the Carl O. Helvie Holistic Cancer Foundation—a foundation different from other cancer foundations in that they focus on the holistic approach and multiple aspects of education, research and patient care for many types of cancer. For each area of content in the book there is a review of current research studies, and steps we can take to avoid carcinogens and strengthen the body. Also included are interviews with over 40 national leaders, discussing vastly different areas ranging from GMOs and EMTs to gratitude and forgiveness. There is also a how-to section that covers everything from meditation, gratitude and faith, to minor changes in diet, drinking water and reducing stress.
A prolific author, Helvie has written 10 books, more than 55 articles, and has presented 57 research papers throughout the US and Europe. In retirement, he focuses his research on natural interventions for health issues, which led him to develop a nursing theory that has helped him establish a nursing center and improve primary care for homeless and low-income families. Since retiring, he has written two more books and served as the host of a holistic health radio show. In 1999, he was presented the Distinguished Career Award in Public Health from the American Public Health Association. He has been interviewed on more than 150 radio and television shows about his two most recent books.
For more information, please visit www.holisticcancerfoundation.com. Or visit https://www.holisticcancerfoundation.com/interviews-cancer-survivors/ to listen to Helvie's interviews with cancer survivors.
Reducing Your Cancer Risk: A Holistic Approach
Booklocker Inc.
Released: 2017
ISBN-13: 978-1634923682
ISBN-10: 1634923685
Available on Amazon.com and holisticcancerfoundation.com
###
Excerpts from reviews on Reducing Your Cancer Risk:
Laura Fabiani, Library of Clean Reads: "Reducing Your Cancer Risk is an excellent and practical resource book chock-full of information that can motivate one to make lifestyle changes that can prevent cancer...The book is divided into three parts. The first discusses Environmental Factors and includes ways to avoid or prevent exposure to risk factors... The second discusses Individual Factors and includes lifestyle choices to increase one's resistance to cancer and build a better immunity... The third discusses Mental and Spiritual Aspects and includes compassion, meditation, forgiveness, prayer and stress management... Although written by an educated man with extensive knowledge, Mr. Helvie keeps the information easy to read and follow by using the format of bullet point suggestions that can be implemented immediately.
If you are looking to lead a healthier lifestyle and want to have a practical manual on what to do to prevent cancer, this is the ideal book for you...The contents page, index and numerous links and references to over 40 other professionals make this book a handy resource that has gained a coveted place on my desk."
NewAgeJournal.com: "Reducing Your Cancer Risk is an essential reference guide for those who want to prevent cancer or are currently struggling with a cancer diagnosis. Western medicine pushes the traditional radiation, chemotherapy and surgery to 'cure' cancer. In reality, these treatments cause cancer to proliferate and kill off healthy cells... In each section, the author describes specific things a person can do to prevent cancer and then provides action steps to assist in implementing these suggestions... This book is very well written and easy to read. In fact, I could not put it down... As a retired hospice and holistic wellness nurse, I really appreciate his all-encompassing approach."
Rev Dr. Anne Marie Evers, Best-Selling Author; Ordained Minister; Doctor of Divinity; CEO of Affirmations International Publishing Company; Radio Host: "I found the book so interesting ... I could not put it down until I had read it from cover to cover. So much of the information we may know or probably have heard about, however the way the author sets it out makes it new, tantalizing and exciting. I was thinking as I read through it, everyone can benefit from reading and using this information... The book covers all aspects of health, diet, exercise, meditation, prayer and much more coupled with a huge dose of 'Common Sense.' ...Put it in a way that is interesting to read and understand."
Cannabis research starting to pay dividends in the UK after Govt ruling, says GlobalData
Following today’s announcement (12 October) from Sajid Javid, UK Home Secretary, that physicians can now prescribe cannabis oil to patients from 1st November,
Rahael Maladwala, Pharma Analyst at GlobalData, offers his view on this landmark ruling:
“This new rule shows that the global surge in the use of medicinal cannabis is demonstrating positive results and the pharmaceutical industry is likely to see similar products come to market in the near future.
“The cannabidiol molecule has been shown to have medicinal properties across various central nervous system indications, including pain, multiple sclerosis, and, epilepsy. The UK government’s decision to legalize cannabis oil for medical use is the first step into moving this molecule into mainstream healthcare.
“Previously, cannabidiol molecules had been placed in Schedule I, under the Misuse of Drugs Regulations 2001, meaning that little research could be carried out but earlier this year it was moved to Schedule II, which opened up the possibility of structured trials to test safety and efficacy.
“While the UK have not gone as far as other countries like Canada and the Netherlands and legalised the recreational use of cannabis, this policy change will be welcome news to patients suffering from serious illnesses where cannabis could be a potential treatment. A prime example of this are epilepsy patients Alfie Dingley and Billy Caldwell, who struggled to get access to cannabis oil despite it alleviating their symptoms. This new rule makes it far easier for doctors to prescribe the drug to these patients.
“This is likely to be seen as a test run for this controversial drug; over the next year the Advisory Council on the Misuse of Drugs (ACMD) will conduct a long term review on the uses of cannabis and the results of that may determine the number of cannabis products that enter the market over the coming years.”
Global Survey and Documentary Film Expose Emotional Impact of Multiple Sclerosis
Not intended for U.S media
- Merck-sponsored survey developed in collaboration with IACO and Eurocarers reveals lifelong effects of caring for a loved one with MS
- #MSInsideOut documentary film, executively produced by Shift.ms, provides artistic take on the experiences of those impacted by MS
DARMSTADT, Germany, Oct. 11, 2018 /CNW/ - Merck, a leading science and technology company, today announced the publication of results from a global Merck-sponsored multiple sclerosis (MS) carer survey, as well as the premiere of the #MSInsideOut documentary film, Seeing MS from the Inside Out, executive produced by Shift.ms, a social network for people with multiple sclerosis, at the 34th Congress of the European Committee for Treatment and Research In Multiple Sclerosis (ECTRIMS), in Berlin, Germany.
To view the Multimedia News Release, please click:
https://www.multivu.com/players/uk/8411851-merck-survey-and-film-multiple-sclerosis/
The 'Living with Multiple Sclerosis: The Carer's Perspective report was developed in collaboration with The International Alliance of Carer Organizations (IACO) and Eurocarers to examine the experiences of 1,050 multiple sclerosis (MS) carers across seven countries (US, Canada, UK, France, Germany, Italy and Spain). The survey found that almost half (48%) of those surveyed became MS carers when they were below the age of 35, and nearly one in three had been caring for somebody for 11 years or more.
Additional key findings from the carer survey included:
- 43% and 28% of carers surveyed reported an impact on their emotional/mental health and physical health respectively
- 34% said being an MS carer impacted their financial situation, more than a third (36%) stated they had to take time off work, and as a result, 84% of those carers reported their work and career being impacted
- Only 15% of carers surveyed connected with other carers or patient organisations to help cope with the challenges of their role
"MS can be a devastating disease for both patients and carers, with the responsibilities assumed by carers over an extended length of time and intensifying as the disease progresses. Carers can experience a profound impact on their physical and emotional health, finances, and employment," said Nadine Henningsen, Board Chair, IACO. "Not surprisingly, the survey results reinforced the large number of young people who are becoming carers - often in a formative time of their life."
As part of the #MSInsideOut campaign, an initiative aimed at providing a deeper understanding of MS, the MS Inside Out documentary film, 'Seeing MS from the Inside Out', will be premiered. Developed with Shift.ms as executive producers, it is the first global documentary film to pair artists and people from across the MS community, with a view to interpreting the experiences and perspectives of those impacted by MS through art.
"In line with our broader mission at Shift.ms, the aim of this documentary is to highlight the individual stories in a unique and innovative way across the MS community, digging deeper into the elements of MS that remain under-represented with a view of interpreting the unmet needs of those impacted by MS through art," said George Pepper, Co-founder and CEO, Shift.ms. "By bringing these stories out into the open we will be able to address those challenges that remain, opening lines of communication and ultimately raising awareness of MS."
The documentary follows three stories: Maria Florencia, a person living with MS from Argentina, Jon Strum, a caregiver from the US, and Dr. Luigi Lavorgna, a healthcare professional from Italy. Each was paired with a local visual artist to bring their stories to life through an emotional interpretation not bound by words but through art, reflecting the often difficult-to-explain nature of MS.
The premiere will take place at 18.00 - 19.30 CEST today on October 11, during ECTRIMS 2018 and can be accessed through a livestream link here: http://www.touch-stream.com/MSinsideout
"At Merck, we are extremely proud to highlight the unmet needs in the community through our work with Shift.ms, IACO and Eurocarers which expose the experiences of different members of the MS community, including the perspective of MS carers, whose voices have traditionally not been heard as strongly," said Andrew Paterson, Senior Vice President, Global Head of Neurology and Immunology, at the biopharma business of Merck. "Forming part of our ongoing company-wide commitment to carers, and connecting with the broader Embracing Carers initiative, the outcomes from both the survey and documentary film highlight the need for additional support and awareness. We therefore encourage and call upon the MS community to take these findings and identify ways in which they can better assist both MS carers and patients."
All Merck Press Releases are distributed by e-mail at the same time they become available on the Merck Website. Please go to http://www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.
About Multiple Sclerosis
Multiple sclerosis (MS) is a chronic, inflammatory condition of the central nervous system and is the most common, non-traumatic, disabling neurological disease in young adults. It is estimated that approximately 2.3 million people have MS worldwide. While symptoms can vary, the most common symptoms of MS include blurred vision, numbness or tingling in the limbs and problems with strength and coordination. The relapsing forms of MS are the most common.
Merck in Multiple Sclerosis
Merck has a long-standing legacy in neurology and immunology, with significant R&D and commercial experience in multiple sclerosis (MS). Merck's current portfolio includes two products for the treatment of relapsing MS, with a robust pipeline focusing on discovering new therapies that have the potential to modulate key pathogenic mechanisms in MS. Merck aims to improve the lives of those living with MS, by addressing areas of unmet needs.
About Merck
Merck is a leading science and technology company in healthcare, life science and performance materials. More than 53,000 employees work to further develop technologies that improve and enhance life - from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2017, Merck generated sales of € 15.3 billion in 66 countries.
Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.
About Embracing Carers
Embracing Carers is a global initiative led by Merck KGaA in collaboration with leading caregiver organizations around the world designed to increase awareness, discussion, and action about the often-overlooked needs of caregivers. Given that caregivers need support and often do not know where to turn for help, Embracing Carers was created to help fill that void.
About IACO
The International Alliance of Carer Organizations (IACO) is a global coalition of 15 member nations committed to building a global understanding and respect for the vital role of family carers. Recognized as an official NGO by the United Nations, IACO works to improve the quality of life and support the needs of carers, through international partnerships and advocacy that strengthens and honors the voice of carers. To learn more, visit http://www.internationalcarers.org.
About Eurocarers
Eurocarers is the European umbrella organisation representing informal carers and their organizations, irrespective of the particular age or health need of the person they are caring for. Eurocarers works to raise awareness of the significant contribution made by carers to care systems while ensuring that all relevant policies across Europe take account of their needs and preferences. To learn more, visit http://www.eurocarers.org.
About Shift.ms
Shift.ms - http://www.Shift.ms - is the social network for people with multiple sclerosis. Founded by MSers, for MSers, the charity supports many thousands of recently diagnosed people across the world as they make sense of MS. It's independent and it's free.
About #MSInsideOut
#MSInsideOut is a campaign supported by Merck which focuses on understanding the journeys people living with MS face and telling the inside story of the disease. For more than 20 years, Merck has been relentlessly focused on understanding the journey people living with MS face to create a meaningful, positive experience for them and the broader MS Community. With the #MSInsideOut campaign Merck aims to better understand MS and, importantly, enable others to do the same.
(Logo: https://mma.prnewswire.com/media/697963/Merck_MS_Inside_Out_Logo.jpg)
Video: https://www.multivu.com/players/uk/8411851-merck-survey-and-film-multiple-sclerosis/
SOURCE Merck
West Park Healthcare Centre unveils plans for new $1.2B Toronto hospital
TORONTO, Oct. 11, 2018 /CNW/ - West Park Healthcare Centre broke ground today on a massive new construction project that will redefine how nature can effectively be integrated into rehabilitative health care.
The project, with a contract value of $1.2 billion, will include construction of a new six-storey hospital overlooking the Humber River valley. The new hospital, scheduled to open in 2023, will feature 80 per cent of the beds being in single-patient rooms, with each inpatient having a private three-piece washroom for improved infection control. There will also be a significant increase in outpatient care space to serve double the current patient volume.
"The work that happens at the West Park Healthcare Centre is incredible," said Premier Doug Ford. "For more than a century they've made a huge difference for countless patients and their families. Our government is proud to support West Park and its healthcare staff."
"This is a very proud moment after a decade of careful planning and extensive consultation, including valuable input from our patients," said Anne-Marie Malek, West Park's President and CEO. "We can now envision welcoming patients in our new, world-class hospital facility and helping them get their lives back."
The West Park development will amplify the role of the 27-acre campus' natural surroundings through terraces on every floor, many outdoor therapeutic spaces as well as numerous trails and gardens. Research shows that connecting and engaging with nature supports the psychological and emotional well-being of patients and their families.
"The redevelopment represents our opportunity to create a new integrated campus of care where nature and healing intersect – inside and out," said Malek.
"The new West Park Healthcare Centre is an important project that will support patients and families in Toronto by providing access to therapeutic spaces for generations to come," said Christine Elliott, Minister of Health and Long-Term Care. "This unique hospital will offer specialized rehabilitative and complex care while focusing on bringing peace of mind to patients rehabilitating from a life-altering illness or injury. I look forward to the opening of this new building in the beautiful Humber River Valley."
West Park Foundation has launched the $80 million Get Your Life Back Campaign – the largest fundraising endeavour in the history of West Park – to support the capital costs of the new hospital. Phase 1 of the Campaign will raise $50 million by 2023, with the Foundation providing an additional $30 million dollars in support to the new hospital over the next 30 years.
To date, more than $21 million has been raised, representing 42 per cent of the Phase 1 goal.
"We are proud to partner in West Park's bold transformation. The Campaign will ensure that the new hospital is a leading-edge facility, and a match for the courage of our patients and the commitment of our staff," says Joanne Cole, CEO of West Park Foundation.
"Our government is committed to making life easier for families, seniors, businesses and students," said Monte McNaughton, Minister of Infrastructure. "That means making smart investments in reliable infrastructure like the new West Park Healthcare Centre, a facility that will improve care for people in our community."
"We are extremely proud to celebrate today's groundbreaking with all of our public and private partners," said Ehren Cory, President and CEO, Infrastructure Ontario. "Our approach to delivering large, important public sector projects like West Park also delivers value for money on government priorities such as health care."
EllisDon Infrastructure Healthcare (EllisDon) has been awarded the fixed-price contract to design, build, finance and maintain the new hospital. The contract is valued at $1.2 billion, which reflects the payments made during construction, the substantial completion payment, and the facility maintenance payments over 30 years.
About West Park Healthcare Centre:
West Park Healthcare Centre helps patients get their lives back by providing specialized rehabilitative and complex care after a life‐altering illness or injury such as lung disease, amputation, stroke, and traumatic musculoskeletal injuries. West Park is building a new hospital and transforming its 27-acre site into an integrated campus of care, enabling the hospital to evolve its rehabilitative programs to meet Ontario's future healthcare needs.
SOURCE West Park Healthcare Centre
Siemens Healthineers Announces the Expansion of Ottawa Manufacturing Facility
- Manufacturing facility in Ottawa, Ontario, to be expanded to support increased manufacturing of point-of-care analyzer
OAKVILLE, ON, Oct. 11, 2018 /CNW/ - Siemens Healthineers has announced that its Ottawa, Ontario manufacturing facility that manufactures the epoc® blood analysis system will be expanded by 5000 square feet to support new manufacturing lines and accommodate growth of the healthcare business worldwide and in Canada.
The epoc system is a handheld, wireless solution that enables comprehensive blood analysis testing at the patient's side on a single room-temperature test card, with results in less than a minute.
"This investment is a critical step toward enabling the growth of our medical technology business in Canada and Ontario by ensuring we have the manufacturing capacity in place to support continued development," said Eric LaFleche, General Manager of Siemens Healthineers in Canada. "We are proud that the skills and experience of staff are recognized, and Canada continues to be known for its technology, skills, and favourable innovative business environment."
The 5000 square-foot expansion is expected to be complete by June 2021, and will complement the company's other point-of-care operations in the United States, United Kingdom, and India.
The point-of-care testing portfolio from Siemens Healthineers includes several solutions designed to provide immediate, convenient, and easy-to-use diagnostic testing. From the emergency department to the physician's office, clinical management decisions can be made immediately and result in improved patient safety, clinical outcomes, and overall patient satisfaction. The Ottawa facility is focused on the manufacture of the epoc blood analysis system, which provides critical caregivers with real-time, laboratory quality test results at the patient's bedside.
The epoc blood analysis system can be used for a wide range of tests including: blood gas, which measures the amount of oxygen and carbon dioxide in the blood that can indicate the presence of certain medical conditions such as kidney disease, heart failure, diabetes, hemorrhage, chemical poisoning, a drug overdose, or shock, among others; electrolytes and metabolytes, which indicate kidney health, blood sugar levels, and levels of electrolytes such as potassium and sodium; lactate that tests for sepsis; creatinine, which indicates kidney function; and blood urea nitrogen that reveals information about how well the kidneys and liver are functioning.
More information on the Siemens Healthineers epoc blood analysis system is available online.
Follow us on Twitter at: https://twitter.com/SiemensHealth
Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services. In fiscal 2017, which ended on September 30, 2017, Siemens Healthineers generated revenue of €13.7 billion and adjusted profit of €2.5 billion and has about 48,000 employees worldwide. Further information is available at www.siemens-healthineers.com.
SOURCE Siemens Healthineers
Harris Williams Advises SlimFast on its Pending Sale to Glanbia plc
Richmond, Virginia, October 11, 2018 – Harris Williams, a preeminent middle market investment bank focused on the advisory needs of clients worldwide for more than 25 years, announces the pending sale of SlimFast, a portfolio company of Kainos Capital, LLC (Kainos), to Glanbia plc (Glanbia). SlimFast is a leading brand of weight management and meal replacement products. The transaction is being led by Tim Alexander, Ryan Freeman, Andy Warczak, and David Stead of Harris Williams’ Consumer Group.
“SlimFast is one of the most recognizable weight management brands in North America and the U.K.,” said Tim Alexander, a managing director at Harris Williams. “With its 40-year history and strong momentum driven by its recent introductions of SlimFast Advanced Nutrition, SlimFast Advanced Energy and SlimFast Keto, the company is one of the fastest growing weight management brands today.”
“SlimFast’s addition to the Glanbia Performance Nutrition global brand portfolio will provide SlimFast with unique opportunities to accelerate growth through continued innovation and increased distribution into new geographies,” said Ryan Freeman, a director at Harris Williams. “We are proud to have represented SlimFast and are excited to follow the company’s future success.”
SlimFast, founded in 1977 and based in Palm Beach Gardens, Florida, offers a clinically-proven plan with delicious meal replacement protein shakes, smoothie mixes, bars, cookies, supplements, 100-calorie snacks and coffee beverages. SlimFast has clinical trials demonstrating proven weight loss. Products can be purchased at mass, grocery and online retailers, in the U.S., Canada, Mexico, U.K. and China.
Kainos is a middle market private equity firm with an exclusive focus on the food and consumer sector. The Kainos team has extensive investment and operating experience in the industry, having invested more than $2 billion of equity in more than 60 transactions with a total transaction value of more than $10 billion. The firm's strategy is to build a diversified portfolio of growing and strategically relevant food and consumer businesses that trade buyers would like to acquire.
Glanbia is a global nutrition company, grounded in nature and science dedicated to providing better nutrition for every step of life’s journey. Glanbia has deep roots in the dairy industry and has become a leading producer and marketer of quality performance nutrition products supporting active lifestyles. Its success as a global ingredients provider has been built on Glanbia’s expertise in nutritional solutions supported by significant investment in research and development. With total group revenues of €3.6 billion in 2017, 6,600 employees and a presence in 32 countries worldwide, Glanbia’s vision is to be one of the world’s top performing nutrition companies, trusted to enrich lives every day.
Harris Williams (www.harriswilliams.com), a subsidiary of the PNC Financial Services Group, Inc. (NYSE:PNC), is a preeminent middle market investment bank focused on the advisory needs of clients worldwide. The firm has deep industry knowledge, global transaction expertise and an unwavering commitment to excellence. Harris Williams provides sell-side and acquisition advisory, restructuring advisory, board advisory, private placements and capital markets advisory services.
Harris Williams’ Consumer Group has completed more than 50 transactions in recent years across a variety of verticals, including branded consumer products; consumer services; food, beverage and agribusiness; and restaurant and retail. For more information on Harris Williams’ Consumer Group and other recent transactions, visit the Consumer Group’s section of the Harris Williams website.
Investment banking services are provided by Harris Williams LLC, a registered broker-dealer and member of FINRA and SIPC, and Harris Williams & Co. Ltd, which is a private limited company incorporated under English law with its registered office at 5th Floor, 6 St. Andrew Street, London EC4A 3AE, UK, registered with the Registrar of Companies for England and Wales (registration number 07078852). Harris Williams & Co. Ltd is authorized and regulated by the Financial Conduct Authority. Harris Williams is a trade name under which Harris Williams LLC and Harris Williams & Co. Ltd conduct business.
|
| Green Relief Inc. The Leading Licensed Producer in Canada to use Aquaponics Technology to Grow Cannabis
-Donating fish used in their aquaponic systems to shelters across the GTA- |
|
| HAMILTON, ON, October 11, 2018 - Green Relief Inc., a licensed producer of medical cannabis in Flamborough, Ontario, has become the world’s leading expert on growing cannabis on a commercial scale using aquaponics. Aquaponics is a sustainable form of agriculture where fish and plants are grown together in a natural ecosystem-based environment. Aquaponics combines the best attributes of aquaculture and hydroponics without the use of chemical additives or having to discard harmful water into the environment. It can produce more than ten times the crop yield per acre and uses 90% less water than conventional farming. |
|
| With the natural resources of our planet being depleted at an alarming rate, Green Relief believes in striving to embed sustainability in every fiber of its company through awareness, involvement, and innovation. They incorporate strong environmental, health, and social values in everything they do from the geothermal advantage of their earth-sheltered building to the 100% use of energy-saving LED lights and environmentally responsible aquaponic growing systems. From their planned integration of job positions for the physically disabled through the Ontario Disability Employment Network to donating organically fed tilapia to the local homeless shelters for people in need.
Green Relief’s team of exceptional horticulturalists, scientists, and aquaponic specialists are committed to and actively engaged in the company’s mandate for sustainability. It’s this greater purpose that has created such a powerful company culture where all the employees are personally engaged in a process where they can actually see how they are improving peoples’ lives and making a difference in the world. Exceptional people growing an exceptional plant.
At Green Relief, the cannabis plants are propagated from carefully selected mother plants that are replaced regularly to ensure that the strong genetics of each strain is maintained for optimum cannabinoid and terpene production. This ensures that medical cannabis is consistent from batch to batch resulting in a dependable and high-quality product. Carefully tracked batches of each plant strain are harvested every two weeks to ensure maximum freshness, quality, and traceability is maintained for their patients.
The highly qualified Quality Assurance team at Green Relief ensures that all procedures and protocols are strictly applied during the growing, harvesting, drying, and extracting processes for their medical cannabis. All their products undergo strict testing by both their in-house scientists and third-party laboratories. Products are tested for potency levels as well as for microbiological contaminants, heavy metals, pesticides, and aflatoxins to ensure that patients are receiving a safe and consistent product in every order. |
|
| Warren Bravo is the co-founder and CEO of Green Relief Inc., a licensed producer devoted to bringing innovation and social responsibility to the medical cannabis industry through the use of aquaponics. In the early 1980’s, Warren became the third-generation of the Bravo family to join the family business, Bravo Cement Contracting. By the early 1990’s, Warren had climbed the ladder to company president, leading the firm to become one of the most significant concrete companies in Canada with a worldwide presence. In 2013, Warren took a leap of faith leaving Bravo Cement to establish Green Relief Inc. with co-founder Steve LeBlanc. Their mission: help patients improve their quality of life while furthering the science of medical cannabis and sustainable agriculture around the world.
Recently, Green Relief has expanded its operations by acquiring a 100,000 sq.ft. Facility in nearby Stoney Creek, Ontario, providing a real boost to the local economy. The facility, which will contain 75,000 sq. ft. of growing area and 25,000 sq. ft. of office space, allows Green Relief to grow its medicinal products on a much larger scale. The building will act as an extension of the company’s headquarters in Flamborough and includes plans for installing a second floor, which will double the production output. Green Relief will be hosting a job fair in the coming months and is very excited to be expanding employment opportunities in the Stoney Creek area by creating approximately 100 new living wage jobs. Green Relief also plans to go public giving an initial public offering (IPO) in the coming months. |
|
| -30-
About Green Relief Inc. Green Relief Inc. is a licensed Canadian producer of medical cannabis under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR) and are fully licensed to produce and sell both dry cannabis products and cannabis oils. Their mission: To help patients improve their quality of life, invest in furthering the science of medical cannabis through meaningful research, and advance sustainable agriculture around the world through aquaponics.
www.greenrelief.ca |
|
|
Hey guys!
I have some amazing news! If you haven’t heard yet...my sponsor Pharmafreak now has online ordering on their new website!
This includes all products and apparel! Use my code and save on your order: Trainitright10 ??????
Just visit www.pharmafreak.com and use Trainitright10 at check out!
